ANTX AN2 Therapeutics Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik AN2 Bio (ANTX)

The EV/Sales valuation demonstrates historical business value ranges, with the metric currently fixed at 0.00. The financial stability of AN2 Therapeutics, Inc. (ANTX) is based on substantial grants and liquid assets without credit encumbrances. Global growth potential is driven by the scaling of unique formulas at a low cost of production. Innovations are implemented through robotic molecule screening and automated research data analysis.

ANTX: Rasio nilai perusahaan marang pendapatan AN2 Therapeutics Inc 23.11.2025 - 20.11.2026

ANTX (AN2 Therapeutics Inc): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:AN2 Therapeutics, Inc.
Produk seri AN2 Therapeutics

This ratio determines the market value of the business, including net debt, per unit of revenue, eliminating the impact of capital structure on the valuation. By analyzing changes in the EV/Sales multiple, an investor can see how the market values the potential for developing antibiotics against rare pulmonary infections relative to the current revenues of AN2 Therapeutics (ANTX) against the backdrop of clinical trial costs.